Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against multi-drug ...
The assembly of outer membrane proteins (OMPs) in Gram-negative bacteria is a fundamental process that underpins bacterial viability and resilience. Central to this process is the β-barrel assembly ...
The Tol-Pal complex maintains bacterial outer membrane (OM) stability by regulating lipid homeostasis. (Left) In Gram-negative bacteria, the OM acts as a protective barrier, blocking entry of harmful ...
Scientists from Cornell University, University of California, San Francisco (UCSF), and elsewhere have found that a surplus of membrane proteins may help bacteria survive antibiotic exposure. These ...
The emergence of multi-drug resistance bacteria and healthcare-associated infections are frequent issues in the treatment of suppurating wounds. A group of researchers has created a bactericidal ...
Scientists at Duke University report they have developed a synthetic antibiotic that could be effective against drug-resistant superbugs and bacteria such as Salmonella, Pseudomonas, and E. coli.
The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections ...
A team led by Paul Hergenrother at the University of Illinois Urbana-Champaign has discovered a new antibiotic that exclusively targets gram-negative bacteria and avoids wiping out the ecosystem of ...
Munich-based smartbax, a biotech developing antibiotics against multi-drug resistant bacteria, has announced the in-licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results